Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting

Kevin Wirth, Stefan Boes, Markus Näpflin, Carola Huber, Eva Blozik

Open source

DOI
10.1136/bmjopen-2023-077454
Published
2023-11
Container
BMJ Open
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2023-077454,
  title = {Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting},
  author = {Kevin Wirth and Stefan Boes and Markus Näpflin and Carola Huber and Eva Blozik},
  year = {2023},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2023-077454},
  url = {https://doi.org/10.1136/bmjopen-2023-077454}
}

RIS

TY  - JOUR
TI  - Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting
AU  - Kevin Wirth
AU  - Stefan Boes
AU  - Markus Näpflin
AU  - Carola Huber
AU  - Eva Blozik
PY  - 2023
JO  - BMJ Open
DO  - 10.1136/bmjopen-2023-077454
UR  - https://doi.org/10.1136/bmjopen-2023-077454
ER  - 

APA

Wirth, K., Boes, S., Näpflin, M., Huber, C., & Blozik, E. (2023). Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting. BMJ Open. https://doi.org/10.1136/bmjopen-2023-077454

Source records